Evidence map›Paper›PMID 27818362›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2017

Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa.

Rashid Ansumana, Samuel Keitell, Gregory M T Roberts, Francine Ntoumi, Eskild Petersen, Giuseppe Ippolito, Alimuddin Zumla

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Rapid and Visual Differentiation ofFrontiers in microbiology · 2021
    Article
  12. TB control in India in the COVID era.The Indian journal of tuberculosis · 2021
    Article
  13. Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview.Tropical medicine and infectious disease · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 6 countries.

Rashid AnsumanaMercy Hospital Research Laboratory, Kulanda Town, Bo, Sierra Leone; Department of Community Health and Clinical Studies, Njala University, Kowama Campus, Bo, Sierra Leone. Electronic address: rashidansumana@gmail.com.
Samuel KeitellDepartment of Community Health and Clinical Studies, Njala University, Kowama Campus, Bo, Sierra Leone.
Gregory M T RobertsDepartment of Community Health and Clinical Studies, Njala University, Kowama Campus, Bo, Sierra Leone.
Francine NtoumiFondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Eskild PetersenInstitute of Clinical Medicine, University of Aarhus, Aarhus, Denmark; The Royal Hospital, Muscat, Oman.
Giuseppe IppolitoLazzaro Spallanzani National Institute for Infectious Diseases, IRCCS, Rome, Italy.
Alimuddin ZumlaCentre for Clinical Microbiology, Division of Infection and Immunity, University College London, and the National Institute of Health Research Biomedical Research Centre at UCL Hospitals, London, UK.
Njala University · SLIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITRoyal Hospital · OMUniversity College London · GBUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization (WHO) Global Tuberculosis Report 2015 states that 28% of the world's 9.6 million new tuberculosis (TB) cases are in the WHO Africa Region. The Mano River Union (MRU) countries of West Africa-Guinea, Sierra Leone, and Liberia-have made incremental sustained investments into TB control programmes over the past two decades. The devastating Ebola virus disease (EVD) outbreak of 2014-2015 in West Africa impacted significantly on all sectors of the healthcare systems in the MRU countries, including the TB prevention and control programmes. The EVD outbreak also had an adverse impact on the healthcare workforce and healthcare service delivery. At the height of the EVD outbreak, numerous staff members in all MRU countries contracted EBV at the Ebola treatment units and died. Many healthcare workers were also infected in healthcare facilities that were not Ebola treatment units but were national hospitals and peripheral health units that were unprepared for receiving patients with EVD. In all three MRU countries, the disruption to TB services due to the EVD epidemic will no doubt have increased Mycobacterium tuberculosis transmission, TB morbidity and mortality, and decreased patient adherence to TB treatment, and the likely impact will not be known for several years to come. In this viewpoint, the impact that the EVD outbreak had on TB diagnostic, management, and prevention services is described. Vaccination against TB with BCG in children under 5 years of age was affected adversely by the EVD epidemic. The EVD outbreak was a result of global failure and represents yet another 'wake-up call' to the international community, and particularly to African governments, to reach a consensus on new ways of thinking at the national, regional, and global levels for building healthcare systems that can sustain their function during outbreaks. This is necessary so that other disease control programmes (like those for TB, malaria, and HIV) are not compromised during the emergency measures of a severe epidemic.

Indexed as

TuberculosisAfrica, WesternDelivery of Health CareHealth PersonnelHemorrhagic Fever, EbolaHumansProgram EvaluationTuberculosis VaccinesVaccinationWorkforceWorld Health OrganizationTuberculosis VaccinesEbolaEpidemicsHealth servicesImpactOutbreakTuberculosis

Identifiers

PMID27818362
PMCPMC7110799
OpenAlexW2548763324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.